In September 2011, the Company’s Board of Directors amended and restated the ESPP. In conjunction with
the amendment of the ESPP, the Company’s Board of Directors determined that the offerings under the ESPP
would commence, beginning with a twelve month offering period starting in December 2011. As of January 31,
2016, $37.5 million has been withheld on behalf of employees for future purchases under the ESPP and is
recorded in accounts payable, accrued expenses and other liabilities. Employees purchased 3.0 million shares for
$155.0 million and 3.3 million shares for $127.8 million, in fiscal 2016 and 2015, respectively, under the ESPP.
Prior to February 1, 2006, options issued under the Company’s stock option plans generally had a term of
10 years. From February 1, 2006 through July 3, 2013, options issued had a term of five years. After July 3,
2013, options issued have a term of seven years.
During fiscal 2016, the Company granted a performance-based restricted stock unit award to the Chairman
of the Board and Chief Executive Officer subject to vesting based on a performance-based condition and a
service-based condition. These performance-based restricted stock units will vest simultaneously if the
performance condition is achieved.
Stock activity excluding the ESPP is as follows:
: Options Outstanding :
Shares Outstanding Weighted-
Available Stock Average Aggregate
: for Grant : : Options : Exercise Price :Intrinsic Value:
Balance as of January 31, 2015 . . . . . . 30,789,538 29,458,361 $44.36
Increase in shares authorized:
2013 Equity Incentive
Plan................. 39,148,364 0 0.00
2014 Inducement Equity
Incentive Plan . . . . . . . . . 231,871 0 0.00
Options granted under all
plans . . . . . . . . . . . . . . . . . . . .. (7,119,327) 7,119,327 78.85
Restricted stock activity . . . . . . . (15,905,661) 0 0.00
Performance restricted stock
(411,471) 0 0.00
Stock grants to board and
advisory board members . . . . . (192,298) 0 0.00
Exercised ................... 0 (8,188,987) 35.53
Plan shares expired . . . . . . . . . . . (1,791,011) 0 0.00
Canceled . . . . . . . . . . . . . . . . . . . 2,129,903 (2,129,903) 46.87
Balance as of January 31, 2016 . . . . . . 46,879,908 26,258,798 $56.26 $386,893,769
Vested or expected to vest . . . . . . . . . . 23,956,184 $54.97 $375,375,548
Exercisable as of January 31, 2016 . . . 9,763,563 $41.99 $254,557,559
The total intrinsic value of the options exercised during fiscal 2016, 2015 and 2014 was $291.3 million,
$250.3 million and $292.3 million respectively. The intrinsic value is the difference between the current market
value of the stock and the exercise price of the stock option.
The weighted-average remaining contractual life of vested and expected to vest options is approximately
4.75 years.
As of January 31, 2016, options to purchase 9,763,563 shares were vested at a weighted average exercise
price of $41.99 per share and had a remaining weighted-average contractual life of approximately 3.3 years. The
total intrinsic value of these vested options as of January 31, 2016 was $254.6 million.
106